Mc Carthy Asset Management, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Mc Carthy Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$1.73 - $3.09 $1,384 - $2,472	-800 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$4.07 - $5.3 $814 - $1,060	200 Added 33.33%	800 $4,000
Q4 2020 Feb 01, 2021	BUY	$4.58 - $7.14 $2,748 - $4,284	600 New	600 $4,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.